Literature DB >> 15712226

Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion.

Joerg-Peter Ritz1, Kai Lehmann, Christoph Isbert, Andre Roggan, Christoph T Germer, Heinz J Buhr.   

Abstract

BACKGROUND AND OBJECTIVES: Laser-induced thermotherapy (LITT) is a promising method for local treatment of liver metastases. The aim of this study was to compare the effect of LITT on lesion size when combined with hepatic arterial microembolization or complete hepatic blood flow occlusion. STUDY DESIGN/
MATERIALS AND METHODS: In a porcine liver model, LITT (30 W 15 minutes) was performed with either normal (n = 12), partially interrupted (arterial microembolization via a hepatic artery catheter n = 12) or completely interrupted hepatic perfusion (Pringle's maneuver, n = 12). LITT lesions were macro- and microscopically assessed after liver dissection.
RESULTS: Hepatic inflow occlusion led to a fourfold increase in lesion volume after arterial microembolization and a ninefold increase after complete interruption (6.3. cm3 vs. 27.1 cm3 vs. 58.8 cm3, P < 0.01).
CONCLUSIONS: Interrupting hepatic perfusion significantly increases lesion volumes in LITT. This beneficial effect can also be achieved in the percutaneous application mode by LITT combined with arterial microembolization via a hepatic artery catheter. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712226     DOI: 10.1002/lsm.20144

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  3 in total

1.  Feasibility of bloodless liver resection using Lumagel, a reverse thermoplastic polymer, to produce temporary, targeted hepatic blood flow interruption.

Authors:  James J Pomposelli; Mohamed Akoad; Sebastian Flacke; James J Benn; Mauricio Solano; Aarti Kalra; Peter N Madras
Journal:  HPB (Oxford)       Date:  2011-11-21       Impact factor: 3.647

2.  [Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment].

Authors:  C-T Germer; H J Buhr; C Isbert
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

3.  Curative in situ ablation of colorectal liver metastases-experimental and clinical implementation.

Authors:  Christoph Isbert; Heinz J Buhr; Joerg-Peter Ritz; W Hohenberger; Christoph-T Germer
Journal:  Int J Colorectal Dis       Date:  2006-11-28       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.